https://doctransparency.com/doctor/tx/webster/alfred-maksoud-1043287022
Medicare Enrolled

Dr. Alfred Maksoud, MD

Pulmonary Disease · Webster, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
501 ORCHARD ST, Webster, TX 77598
2815578555
In practice since 2006 (20 years)
NPI: 1043287022 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Maksoud from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Maksoud? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Maksoud

Dr. Alfred Maksoud is a pulmonary disease in Webster, TX, with 20 years in practice. Based on federal Medicare data, Dr. Maksoud performed 3,068 Medicare services across 2,082 unique beneficiaries.

Between the years covered by Open Payments, Dr. Maksoud received a total of $16,710 from 51 pharmaceutical and/or device companies across 766 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Maksoud is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 9% volume in TX$ $16,710 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,068
Medicare services
Top 9% in TX for pulmonary disease
2,082
Unique beneficiaries
$98
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~153 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)857$96$175
Hospital follow-up visit, moderate complexity603$63$115
Test to measure expiratory airflow and volume changes before and after medication administration198$30$400
Critical care, first 30-74 min170$175$350
Test to determine lung volumes using sensors164$44$300
Test to examine how well the lungs exchange gases164$46$300
Office visit, established patient (20-29 min)162$69$125
New patient office visit (45-59 min)125$126$225
Sleep study including heart rate, breathing, and sleep time101$115$250
Initial hospital admission, high complexity94$141$325
EEG, extended monitoring89$359$650
Hospital follow-up visit, high complexity73$96$150
New patient office visit (30-44 min)49$82$155
Evaluation of use of breathing device35$14$30
Sleep study in sleep lab (6 years or older)33$479$2,300
Test for exercise-induced lung stress32$23$35
Sleep study in sleep lab with continuous airway pressure (6 years or older)28$498$2,500
Irrigation and suction of lung airways to obtain cells using an endoscope20$20$600
Test to measure rate of airflow18$32$150
Telephone medical discussion with physician, 21-30 minutes16$84$150
Initial hospital admission, moderate complexity13$107$275
Smoking and tobacco use intensive counseling, 4-10 minutes13$13$25
Emergent insertion of breathing tube into windpipe using an endoscope11$116$200
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$16,710
Total received (2018-2024)
Avg $2,387/year across 7 years
Top 13% in TX for pulmonary disease
51
Companies
766
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,710 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,087
2023
$2,793
2022
$2,674
2021
$1,646
2020
$2,420
2019
$2,891
2018
$1,199

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$2,491
AstraZeneca Pharmaceuticals LP
$2,170
Pulmonx Corporation
$1,670
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,082
Actelion Pharmaceuticals US, Inc.
$958
Veran Medical Technologies, Inc.
$747
Harmony Biosciences LLC
$740
Regeneron Healthcare Solutions, Inc.
$679
Electromed, Inc.
$513
GENZYME CORPORATION
$455
Inspire Medical Systems, Inc.
$397
Grifols USA, LLC
$386
Philips Electronics North America Corporation
$378
Mylan Specialty L.P.
$342
Insmed, Inc.
$340
Amgen Inc.
$277
Mallinckrodt Hospital Products Inc.
$247
Sunovion Pharmaceuticals Inc.
$243
United Therapeutics Corporation
$240
Intuitive Surgical, Inc.
$227
HARMONY BIOSCIENCES LLC
$187
Novartis Pharmaceuticals Corporation
$184
ABBVIE INC.
$152
Genentech USA, Inc.
$148
Bayer HealthCare Pharmaceuticals Inc.
$142
Philips North America LLC
$120
Takeda Pharmaceuticals U.S.A., Inc.
$105
JAZZ PHARMACEUTICALS INC.
$102
Shionogi Inc
$102
Tactile Systems Technology Inc
$97
Teva Pharmaceuticals USA, Inc.
$97
Avadel CNS Pharmaceuticals, LLC
$95
PFIZER INC.
$85
Jazz Pharmaceuticals Inc.
$78
Merck Sharp & Dohme LLC
$55
Inari Medical, Inc.
$50
Circassia Pharmaceuticals Inc
$42
Resmed Corp
$39
Allergan, Inc.
$32
E.R. Squibb & Sons, L.L.C.
$30
ANI Pharmaceuticals, Inc.
$25
Baxter Healthcare
$25
Axsome Therapeutics, Inc.
$25
Gilead Sciences, Inc.
$19
IDORSIA PHARMACEUTICALS US INC
$19
Inogen, Inc.
$17
Advanced Respiratory, Inc
$13
Phadia US Inc.
$13
Allergan Inc.
$11
Janssen Pharmaceuticals, Inc
$10
bioMerieux
$9
Top 3 companies account for 37.9% of total payments
Associated products mentioned in payments ›
(8874) inCourage · (AK6) Vest Therapy · ACTHAR · AIRSENSE · AIRSUPRA · ANORO · ANORO ELLIPTA · AREXVY · AVYCAZ · Adempas · AirDuo Digihaler · Arikayce · Astral · BEVESPI AEROSPHERE · BREO · BREO ELLIPTA · BREZTRI · BREZTRI AEROSPHERE · BROVANA · CHANTIX · CHARTIS CATHETER · CINQAIR · CT THROMBECTOMY SYSTEM KIT · DALVANCE · DUPIXENT · Da Vinci Surgical System · ELIQUIS · Esbriet · FASENRA · FLOWTRIEVER CATHETER · Fetroja · Flexitouch Plus · GLASSIA · HYQVIA · Hillrom - Life 2000 Ventilation System · IMFINZI · INSPIRE · ImmunoCAP · InogenOne · LONHALA MAGNAIR · LUMRYZ · NUCALA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · PREVNAR 20 · PURIFIED CORTROPHIN GEL · Perforomist · ProAir Digihaler · Prolastin-C · Prolastin-C Liquid · Pulmonx Endobronchial Valve EBV · QUVIVIQ · REMODULIN · Repatha · Respiratoriy Care Undiv · S · SHINGRIX · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · Spin · Sunosi · TAVNEOS · TEFLARO · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Vest System Model 105 Home Care · Trilogy 100 · UPTRAVI · Utibron · VIDAS BRAHMS PCT · WAKIX · Wakix · Wellcentive Undiv · XARELTO · XOLAIR · XYWAV · Xolair · Xyrem · YUPELRI · Yupelri · ZEPHYR DELIVERY CATHETER · ZERBAXA · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $545 per 100 Medicare services performed
Looking for a pulmonary disease in Webster?
Compare pulmonary diseases in the Webster area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary Diseases within 10 mi
102
Per 100K population
2.1
County median income
$73,104
Nearest hospital
HCA HOUSTON HEALTHCARE CLEAR LAKE
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Maksoud is a clinical cardiology specialist, with above-average Medicare volume (top 9% in TX), and high industry engagement (low-engagement, top 13%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Maksoud experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Maksoud performed 857 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Maksoud receive payments from pharmaceutical companies?
Yes. Dr. Maksoud received a total of $16,710 from 51 companies across 766 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Maksoud's costs compare to other pulmonary diseases in Webster?
Dr. Maksoud's average Medicare payment per service is $98. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Maksoud) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →